文献速递烧伤创面修复

异体皮移植对20-50%体表面积大面积烧伤住院结局的影响:倾向性评分匹配分析

The impact of skin allograft on inpatient outcomes in the treatment of major burns 20-50% total body surface area - A propensity score matched analysis using the nationwide inpatient sample.
PubMed 文献 · Burns · 2018-12-05

该研究基于美国全国住院患者样本(NIS)中3557例20-50%体表面积、需手术的大面积烧伤患者,采用倾向性评分匹配评估异体皮移植与住院结局的关系。匹配后771例异体皮患者与1774例对照配对,异体皮与住院死亡率平均处理效应(ATE)增加2.8%(95%CI 0.2-5.3%,p=0.041)相关,并发症、住院日、手术次数与费用亦显著升高。作者认为需更高质量研究论证这一昂贵有限资源在中等面积大面积烧伤中的应用。

要点

  • 20-50%TBSA需手术烧伤中,异体皮与住院死亡率ATE增加2.8%相关(95%CI 0.2-5.3%,p=0.041)
  • 异体皮组并发症指数、住院日、手术次数与总费用均显著升高
  • 该人群异体皮应用指征需更高质量研究支持,不宜默认常规使用

核心结论

  • 在20-50%TBSA大面积烧伤手术患者中,异体皮使用与住院死亡率显著增加相关。
  • 同时与住院并发症增多、住院时间延长、烧伤手术次数增加及总费用升高相关。
  • 作者呼吁更高质量研究论证异体皮在这一中等面积烧伤人群中的应用。

研究设计与样本

  • 回顾性队列研究,数据来自美国Nationwide Inpatient Sample(NIS)、HCUP、AHRQ的出院记录。
  • 纳入3557例>二度深度且20-50%TBSA、接受手术治疗的烧伤患者。
  • 采用倾向性评分匹配评估结局,匹配后771例异体皮患者与1774例对照配对。
  • 匹配后协变量平均标准化差异均<11%。
  • 主要结局为死亡率,次要结局包括并发症、住院时间、烧伤手术总数与费用。

主要发现

  • 异体皮对住院死亡率的平均处理效应(ATE)为增加2.8%(95%CI 0.2-5.3%,p=0.041)。
  • 复合并发症指数ATE增加0.13(95%CI 0.07-0.20,p<0.001)。
  • 住院时间ATE延长8.4天(95%CI 6.1-1.9天,p<0.001;原文如此)。
  • 烧伤手术总数ATE增加1.6(95%CI 1.4-1.9,p<0.001)。
  • 总费用ATE增加139,476美元(95%CI 100,716-178,236,p<0.001)。

临床怎么用

  • 对20-50%TBSA需手术烧伤患者,异体皮覆盖应审慎评估指征,不宜默认作为常规 temporizing 覆盖。
  • 使用异体皮前应向患者及家属交代住院死亡风险、并发症、住院日、再手术次数与费用可能增加。
  • 将异体皮视为昂贵且有限的资源,优先用于有明确创面床评估或覆盖需求、且风险可接受的患者。

局限性

  • 为基于行政出院数据的回顾性分析,存在编码与混杂局限。
  • 倾向性评分匹配虽使协变量平均标准化差异<11%,但不能排除未测量混杂。
  • 原文未报告异体皮具体应用指征、时机与移植方式等细节。
  • 结论提示需更高质量研究,当前证据不足以确立因果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human cadaveric skin (allograft) is used in treating major burns both as temporizing wound coverage and a means of testing wound bed viability following burn excision. There is limited information on outcomes, and clinicians disagree on indications for application in intermediate-sized burns. This study aims to improve understanding of allograft use in 20-50% total body surface burns by assessing current utilization and evaluating inpatient outcomes. METHODS: Discharge data from the Nationwide Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality assessed 3557 major burn patients (>second degree depth and 20-50% TBSA) undergoing operative treatment. Outcomes were evaluated with propensity score matching. The primary outcome was mortality with secondary outcomes including complications, length of stay, total burn operations, and charges. RESULTS: After matching, 771 allografted patients were paired with 1774 controls. Covariate mean standard differences were all <11% after matching. The average treatment effect (ATE) of allograft on inpatient mortality was an increase of 2.8% (95% CI 0.2-5.3%, p=0.041). Allograft ATEs were all significantly higher for secondary outcomes: composite complication index increased 0.13 (95% CI 0.07-0.20, p<0.001), length of stay 8.4days (95% CI 6.1-1.9 days, p<0.001), total burn operations 1.6 (95% CI 1.4-1.9, p<0.001), and total charges $139,476 [$100,716-178,236, p<0.001). CONCLUSIONS: Allograft use in major burns 20-50% TBSA was associated with a significant increase in inpatient mortality. There was a notable correlation with increased inpatient complications, longer length of stay, more burn operations, and greater total charges. Better studies are needed to justify the use of this costly and limited resource in the intermediate sized major burn population.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Sheckter CC, Li A, Pridgen B, et al. The impact of skin allograft on inpatient outcomes in the treatment of major burns 20-50% total body surface area - A propensity score matched analysis using the nationwide inpatient sample. Burns. 2018. PMID: 30527451. doi:10.1016/j.burns.2018.08.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。